Skip to main content

Table 1 Stage I-IV patients’ characteristics and clinical features

From: The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

Parameters Group (no.) MST (mo) HR P
FIGO I-IIA (76) 60   
IIB-IV(13) 30 2.629(1.201–5.727) 0.016
Size 4 cm (47) 65   
>4 cm (42) 49 2.027(1.087–3.780) 0.026
LNM No (50) 68   
Yes(23) 44 2.573(1.269–5.216) 0.009
LVSI No (46) 69   
Yes(27) 46 2.443 (1.197–4.986) 0.014
DOI 2/3 (57) 67   
>2/3(16) 51 2.165(0.931–5.035) 0.073
NACT No (35) 60   
Yes(38) 59 1.166(0.567–2.401) 0.676
Radiotherapy No (66) 61   
Yes(23) 37 1.345 (0.676–2.678) 0.398
Syn No (8) 36   
Yes(39) 58 1.671 (0.383–7.280) 0.494
CD56 No (12) 77   
Yes(30) 52 1.844 (0.606–5.612) 0.281
CgA No (15) 76   
Yes(31) 50 1.933 (0.635–5.882) 0.246
NSE No (6) 44   
Yes (10) 55 0.837 (0.197–3.549) 0.809